Article

Tseng, Ping-Tao ORCID: https://orcid.org/0000-0001-5761-7800, Zeng, Bing-Syuan, Hsu, Chih-Wei ORCID: https://orcid.org/0000-0002-8650-4060, Thompson, Trevor ORCID: https://orcid.org/0000-0001-9880-782X, Stubbs, Brendon, Hsueh, Po-Ren, Su, Kuan-Pin, Chen, Yen-Wen, Chen, Tien-Yu, Wu, Yi-Cheng, Lin, Pao-Yen, Carvalho, Andre F, Li, Dian-Jeng, Yeh, Ta-Chuan, Sun, Cheuk-Kwan, Cheng, Yu-Shian, Shiue, Yow-Ling, Liang, Chih-Sung ORCID: https://orcid.org/0000-0003-1138-5586 and Tu, Yu-Kang (2023) The difference in all-cause mortality between COVID-19 patients treated with standard of care plus placebo and those treated with standard of care alone: a network meta-analysis of randomised controlled trials of immunomodulatory kinase inhibitors. Journal of the Royal Society of Medicine. pp. 1-12. ISSN 0141-0768 (Print), 1758-1095 (Online) (doi:10.1177/01410768231202657)